Pilot study assesses antibody response to third COVID-19 vaccine dose in kidney transplant recipients

By | August 10, 2021
A pilot study has begun to assess the antibody response to a third dose of an authorized COVID-19 mRNA vaccine in kidney transplant recipients who did not respond to two doses of the Moderna or Pfizer-BioNTech COVID-19 vaccine.